Skip to content
10-Q

Quarterly Report

Biofrontera Inc. BFRI BFRIW

0001493152-26-023119

← back to feed
Filed
May 14, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 13, 2026 12.8M sh
Shares Diluted Q1 2026 · Mar 31, 2026 11.68M sh
Shares Diluted Q1 2026 · Mar 31, 2025 8.87M sh
Capex Q1 2026 · Mar 31, 2026 $5K
Capex Q1 2026 · Mar 31, 2025 $3K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$70K
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$4.12M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $6.32M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $6.39M
Stockholders Equity Q1 2026 · Mar 31, 2026 $6.07M
Stockholders Equity Q1 2026 · Dec 31, 2025 $10.48M
Stockholders Equity Q1 2026 · Mar 31, 2025 $469K
Stockholders Equity Q1 2026 · Dec 31, 2024 $4.43M
Current Liabilities Q1 2026 · Mar 31, 2026 $10.92M
Current Liabilities Q1 2026 · Dec 31, 2025 $11.9M
Total Liabilities Q1 2026 · Mar 31, 2026 $18.72M
Total Liabilities Q1 2026 · Dec 31, 2025 $18.08M
Current Assets Q1 2026 · Mar 31, 2026 $13.16M
Current Assets Q1 2026 · Dec 31, 2025 $18.08M
Total Assets Q1 2026 · Mar 31, 2026 $24.79M
Total Assets Q1 2026 · Dec 31, 2025 $28.56M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.41
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.47
Eps Basic Q1 2026 · Mar 31, 2026 −$0.41
Eps Basic Q1 2026 · Mar 31, 2025 −$0.47
Sga Expense Q1 2026 · Mar 31, 2026 $10.99M
Sga Expense Q1 2026 · Mar 31, 2025 $8.65M
Rd Expense Q1 2026 · Mar 31, 2026 $900K
Rd Expense Q1 2026 · Mar 31, 2025 $1.21M
Net Income Q1 2026 · Mar 31, 2026 −$4.75M
Net Income Q1 2026 · Mar 31, 2025 −$4.2M
Operating Income Q1 2026 · Mar 31, 2026 −$4.32M
Operating Income Q1 2026 · Mar 31, 2025 −$4.55M
Revenue Q1 2026 · Mar 31, 2026 $10.08M
Revenue Q1 2026 · Mar 31, 2025 $8.59M